Sodium-glucose cotransporter 2 inhibitors are associated with reduced circulating activin A and modulation of BMP/activin signaling in ischemic cardiomyopathy with high echocardiographic probability of pulmonary hypertension
GeroScience
The paper
Madonna R, Del Boccio P, Borghini A et al.
GeroScience · 31 Aug 2026
